Published in Transplant Proc on May 01, 2001
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32
HLA-G and its role in implantation (review). J Assist Reprod Genet (2007) 0.92
The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J (2012) 0.91
Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med (2009) 0.86
Some basic aspects of HLA-G biology. J Immunol Res (2014) 0.80
Infection and HLA-G molecules in nasal polyposis. J Immunol Res (2014) 0.79
Impact of HLA-G in the outcome of vitiligo in Tunisian patients. Indian J Dermatol (2010) 0.75
Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions. World J Methodol (2014) 0.75
Role of HLA-G and NCR in protection of umbilical cord blood haematopoietic stem cells from NK cell mediated cytotoxicity. J Cell Mol Med (2011) 0.75
The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate. Clin Rheumatol (2016) 0.75
Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci U S A (1990) 3.09
Antibody-induced redistribution of HL-A antigens at the cell surface. Eur J Immunol (1972) 2.58
Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J Exp Med (1994) 2.50
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A (1997) 2.14
Non-isotopic and sensitive method for diagnosis of maternally-inherited diabetes and deafness. Diabetologia (1994) 2.03
[The Center for the Study of Human Polymorphism]. Presse Med (1986) 1.94
Genetics of HLA disease association. Annu Rev Genet (1981) 1.74
The major histocompatibility complex in man. Science (1981) 1.72
A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1985) 1.69
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A (1998) 1.63
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol (1978) 1.58
Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci U S A (2001) 1.53
Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci U S A (1984) 1.52
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51
HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol (2001) 1.50
An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells. J Exp Med (1980) 1.50
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol (1999) 1.46
Analysis of 221 renal transplants: influence of cross-reactions between donor and recipient HL-A antigens. Transplant Proc (1971) 1.45
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A (1997) 1.44
SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). Proc Natl Acad Sci U S A (1999) 1.44
Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat Med (1998) 1.44
HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol (1999) 1.41
Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40
[Physical activity and exercise training for patients with cystic fibrosis]. Rev Mal Respir (2010) 1.39
Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A (2001) 1.38
HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages. Hum Immunol (1982) 1.37
A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms. Tissue Antigens (1978) 1.35
The association of the HL-A antigens with diseases. Clin Immunol Immunopathol (1974) 1.34
Polymorphic restriction endonuclease fragment segregates and correlates with the gene for HLA-B8. Proc Natl Acad Sci U S A (1983) 1.33
Clusters of HLA class II beta restriction fragments describe allelic series. Proc Natl Acad Sci U S A (1984) 1.32
A study of HL-A antigens in human organs. Transplantation (1970) 1.32
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32
Production of erythropoietin-like activity by a murine erythroleukemia cell line. Proc Natl Acad Sci U S A (1983) 1.30
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations. J Exp Med (1987) 1.28
The HL-A system sub-loci and their importance in transplantation. Transplant Proc (1969) 1.27
Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol (1999) 1.26
Ranks of donor-recipient histocompatibility for human transplantation. Science (1970) 1.24
Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood (1995) 1.24
Use of the Auto-Analyzer to perform serological tests for syphilis. Study of 1,009 sera using a complement fixation test with the cardiolipidic antigen. Int Arch Allergy Appl Immunol (1967) 1.23
An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A (1994) 1.23
Serologic factors in human transplantation. Ann Surg (1967) 1.22
HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families. Tissue Antigens (1982) 1.19
Theoretical analysis of a physical mapping strategy using random single-copy landmarks. Proc Natl Acad Sci U S A (1991) 1.19
Improved control of partial DNA restriction enzyme digest in agarose using limiting concentrations of Mg++. Nucleic Acids Res (1989) 1.18
Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens (2003) 1.18
Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol (2000) 1.18
Immunoferritin study of the distribution of HL-A antigens on human blood cells. J Immunol (1971) 1.17
Human transplantation antigens: the HL-A (Hu-1) system and its homology with the mouse H-2 system. Transplantation (1968) 1.17
HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol (1999) 1.16
Critical evaluation of histocompatibility in 179 renal transplants. Lancet (1971) 1.16
HLA-G: a shield against inflammatory aggression. Trends Immunol (2001) 1.15
The "Sardinian" HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication? Immunogenetics (1989) 1.14
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol (2001) 1.12
HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis (1982) 1.11
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res (2001) 1.10
Probable heploid expression of HL-A antigens on human spermatozoon. Nature (1970) 1.10
Rosette-forming T cells in human peripheral blood at different ages. Cell Immunol (1974) 1.10
First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination. Hum Genet (1986) 1.10
Analysis of HLA class I genes with restriction endonuclease fragments: implications for polymorphism of the human major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.09
Implication of HLA-G molecule in heart-graft acceptance. Lancet (2000) 1.09
T cell response to Hu-D peptides in patients with anti-Hu syndrome. J Neurooncol (2005) 1.09
Physical association between MHC class I molecules and immunogenic peptides. Nature (1989) 1.08
Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J Immunol (1998) 1.07
The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun (2009) 1.07
Drug-induced hemolysis. Annu Rev Med (1967) 1.06
Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation. J Immunol (1979) 1.06
Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment. Nat Genet (1993) 1.06
DNA polymorphism of HLA class I and class II regions. Immunol Rev (1985) 1.06
Gastric emptying in infants with or without gastro-oesophageal reflux according to the type of milk. Eur J Clin Nutr (1990) 1.05
Decline of natural killer cell activity in sublethally irradiated mice. J Natl Cancer Inst (1978) 1.05
A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem (2000) 1.05
Some contributions of the HL-A complex to the genetics of human diseases. Transplant Rev (1975) 1.05
Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation. J Immunol (2001) 1.04
Letter: HL-A antigen W27--a genetic link between ankylosing spondylitis and Reiter's syndrome? N Engl J Med (1974) 1.04
HLA and susceptibility to Hodgkin's disease. Immunol Rev (1983) 1.04
p21WAF-1 reorganizes the nucleus in tumor suppression. Proc Natl Acad Sci U S A (1998) 1.04
NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. Leukemia (2008) 1.04